Image (Ab2e9c42 2421 421d B7c7 9539cb6dcb08 01)
Chemical structure of atorvastatin calcium as shown in the image.*
Atorvastatin Calcium
Product Images NDC 67296-2053
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 67296-2053). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Redpharm Drug, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Image (Ab2e9c42 2421 421d B7c7 9539cb6dcb08 02)
A line graph comparing the cumulative incidence percentage of two groups over a period of 3.5 years. One line represents atorvastatin, and the other represents placebo, showing lower cumulative incidence for atorvastatin. The horizontal axis measures time in years, and the vertical axis shows cumulative incidence (%) with a hazard ratio and p-value indicated on the chart.*
Image (Ab2e9c42 2421 421d B7c7 9539cb6dcb08 03)
A line graph depicting cumulative hazard percentages over time for atorvastatin versus placebo. The x-axis represents time to first primary endpoint across a four-year follow-up period, with atorvastatin showing a lower cumulative hazard compared to placebo. A hazard ratio of 0.63 with a confidence interval (0.48–0.83) and p-value of 0.001 is indicated.*
Image (Ab2e9c42 2421 421d B7c7 9539cb6dcb08 04)
A line graph comparing the percentage of subjects experiencing a first major cardiovascular event over time for atorvastatin 10 mg and atorvastatin 80 mg doses. The x-axis represents time in years up to 5 years, and the y-axis shows the percentage of subjects. The graph includes hazard ratio and p-value statistics for the comparison.*
Image (Ab2e9c42 2421 421d B7c7 9539cb6dcb08 05)
Label for Atorvastatin Calcium Tablets USP 10 mg showing 90 tablets per container. The label includes storage instructions at 20 to 25°C and mentions the product is Rx only. Manufactured for Biocon Pharma Inc. and by Graviti Pharmaceuticals Pvt. Ltd., with a barcode and NDC 70377-027-11 visible. The label also notes the tablets are film-coated and contain atorvastatin calcium equivalent to 10 mg atorvastatin.*
Image (Ab2e9c42 2421 421d B7c7 9539cb6dcb08 06)
Packaging label for Atorvastatin Calcium Tablets USP 20 mg from Biocon. The label indicates 90 tablets Rx only with storage instructions between 20° to 25°C. It lists Biocon Pharma Inc. as the manufacturer in New Jersey, USA, and Graviti Pharmaceuticals Pvt. Ltd. in Telangana, India, as the manufacturing site. The label includes a barcode and an unvarnished area.*
Image (Ab2e9c42 2421 421d B7c7 9539cb6dcb08 07)
Atorvastatin Calcium Tablets, USP 40 mg film-coated tablets label. The package contains 90 tablets. The label includes storage instructions to keep between 20° to 25°C, and notes it is manufactured for Biocon Pharma Inc., Iselin, NJ, USA, and by Graviti Pharmaceuticals Pvt. Ltd., Telangana, India. It displays the NDC 70377-029-11 and the Biocon logo.*
Image (Ab2e9c42 2421 421d B7c7 9539cb6dcb08 08)
Atorvastatin Calcium Tablets USP 80 mg film-coated tablet label showing a package of 30 tablets. The label includes storage instructions, dosing note, manufacturer as Biocon Pharma Inc., and manufacturer details for Graviti Pharmaceuticals Pvt. Ltd. The NDC on the label is 70377-030-11.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
